Pierre Biron
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
Papers in
- Co-authors
- Thierry PhilipJean‐Yves BlayFranck ChauvinBertrand CoiffierJean‐Yves CahnAnton HagenbeekCesare GuglielmiDominique Bron
- Journals
- Journal of Clinical Oncology (25 papers)Blood (25 papers)Annals of Oncology (12 papers)European Journal of Cancer (9 papers)Cancer (6 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Pierre Biron
284 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Pathology and Forensic Medicine 4.5k
- Genetics 2.0k
- Oncology 4.7k
- Neurology 2.3k
- Hematology 1.6k
Countries citing papers authored by Pierre Biron
This map shows the geographic impact of Pierre Biron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Biron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Biron more than expected).
Fields of papers citing papers by Pierre Biron
This network shows the impact of papers produced by Pierre Biron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Biron. The network helps show where Pierre Biron may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Biron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 2 | |
| 2 | 2013 | 8 | |
| 3 | Outcome of patients with PDGFRA D842V mutant gastrointestinal stromal tumor (GIST) treated with imatinib (IM) for advanced disease. A study performed with the EORTC Soft Tissue and Bone Sarcoma Group | 2010 | 2 |
| 4 | 2009 | 49 | |
| 5 | 2008 | 59 | |
| 6 | 2007 | 1 | |
| 7 | 2005 | 39 | |
| 8 | 2005 | 169 | |
| 9 | Pharmacovigilance from A to Z : adverse drug event surveillance | 2002 | 5 |
| 10 | 2001 | 1 | |
| 11 | Standards, Options et Recommandations (SOR) pour la surveillance et la prévention des infections nosocomiales en cancérologie | 2000 | 5 |
| 12 | Standards, Options and Recommendations (SOR)for the surveillance and the prevention of cross infections in oncology | 2000 | 1 |
| 13 | Cholestatic hepatitis: ticlopidine suspected. | 1995 | 5 |
| 14 | A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG/KG/DAY (GLYCOSYLATED RHU-G-CSF) | 1993 | 4 |
| 15 | The impact of megatherapy on response and survival in high-risk Ewing's sarcoma. A report of the EBMT solid tumor registry | 1992 | 3 |
| 16 | 1992 | 12 | |
| 17 | 1989 | 6 | |
| 18 | Dissociation between clinical and exercise responsiveness to beta-blockade in angina. | 1978 | 1 |
| 19 | 1977 | 43 | |
| 20 | Free pulmonary passage of dopamine. | 1972 | 10 |
About Pierre Biron
Pierre Biron is a scholar working on Genetics, Neurology, Medical Terminology, Pathology and Forensic Medicine and Oncology, having authored 292 papers that have together received 10.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (63 papers), Neuroblastoma Research and Treatments (31 papers), CNS Lymphoma Diagnosis and Treatment (28 papers), Testicular diseases and treatments (27 papers), Viral-associated cancers and disorders (26 papers), Glioma Diagnosis and Treatment (24 papers), Neutropenia and Cancer Infections (23 papers) and Chronic Lymphocytic Leukemia Research (22 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.5k citations), Genetics (2.0k citations), Oncology (4.7k citations), Neurology (2.3k citations) and Hematology (1.6k citations). Pierre Biron has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Thierry Philip, Jean‐Yves Blay, Franck Chauvin, Bertrand Coiffier, Jean‐Yves Cahn, Anton Hagenbeek, Cesare Guglielmi, Dominique Bron, Pieter Sonneveld and J L Harousseau. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, European Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.